Add this topic to your myFT Digest for news straight to your inbox
Brash biotech entrepreneur could face years in prison when sentenced
Prosecutors allege he ran hedge fund as though it were a ‘Ponzi-like’ scheme
Drugmaker seeks protection from creditors in US courts days after its shares were suspended
Gouging has made reform inevitable; it should be market-based
FBI arrests Turing Pharmaceuticals chief on securities fraud charges
A combative 32-year-old propels the issue of US drug costs into the headlines, writes David Crow
International Edition